Concomitant medical products: product id 8780 lot# serial# (b)(4) product type catheter.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(4), ubd: 25-jun-2023, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
It was reported that the patient was twiddling with their pump which then resulted in a catheter revision today, (b)(6) 2023.It was reported that they ended up replacing the pump segment /pump connector piece.It was reported that they were able to change out the pump segment and they wanted to know what the bolus would be if they prime the new pump segment.Technical services reviewed information.The issue was resolved with a catheter revision today.Additional information received from the healthcare provider (hcp) via company representative (rep) indicated the pump had flipped and they couldn't refill it so they decided to do a dye study.It was reported they performed the dye study and couldn't aspirate which led to the catheter revision.It was reported the drug in the pump was hydromorphone, 650 mcg/ml at 198 mcg/day.
|